Ardena's drug product manufacturing facility in Somerset Advanced drug product manufacturing facility acquired by Ardena in ...

The Contract Manufacturing Organization (CMO) in the pharmaceutical industry plays a pivotal role in bringing drug products to market. This critical function involves managing various aspects of drug ...

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, ...

To maintain market presence, contract manufacturing organizations (CMOs) have consistently demonstrated commitment to maintaining the highest levels of quality assurance, instilling confidence in ...

DUBLIN--(BUSINESS WIRE)--The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression ...

Unlike other global contract manufacturing organizations, Samsung Biologics differentiates itself by focusing on biologics modalities. Biologics are large-molecule treatments made from living ...

Beacon MedTech Solutions recently announced that Phil Littlefield will serve as director of operations, effective immediately. With a track record of success in global manufacturing, ...

On Tuesday, the company disclosed that it had signed a large-scale contract manufacturing organization agreement with a European pharmaceutical company. The contract runs until Dec. 31 ...

with an undisclosed U.S. pharmaceutical firm to provide contract manufacturing organization (CMO) services. The deal represents 3.01 percent of the U.S. company’s annual revenue last year ...

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of ...

The collaboration leverages Thermo Fisher’s Accelerator™ Drug Development services, 360° Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO ...

"We thank our stockholders for their support through our time as a public company and the duration of this process,” said Nick Green, president and CEO of Avid Bioservices. "We look forward to ...